Mereo Biopharma Group (MREO) Q1 2024 Earnings

15MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.04
-0.03
-0.01
0

Details

Expected EPS
N/A
Actual EPS
-0.01
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Mereo Biopharma Group (MREO) has reported earnings of -0.01 per share for Q1 2024.

0 Comments

Share your thoughts